40
Participants
Start Date
October 30, 2019
Primary Completion Date
July 1, 2020
Study Completion Date
July 1, 2020
Scalp block
Patients will be randomly divided into two groups using a computer generated random number chart. Group S received scalp block with 20 ml of 0.5% bupivacaine, whereas Group C will not receive any intervention and will be considered as control group.
Control Group
Patients will be randomly divided into two groups using a computer generated random number chart. Group S received scalp block with 20 ml of 0.5% bupivacaine, whereas Group C will not receive any intervention and will be considered as control group.
Raham Hasan, Cairo
Ain Shams University
OTHER